期刊文献+

亲水凝胶骨架材料制备盐酸帕罗西汀缓释片的可行性研究 被引量:2

Feasibility Study of Paroxetine Hydrochloride Extended-release Tablets Prepared with Gel-forming Matrix Material
原文传递
导出
摘要 目的采用亲水凝胶骨架材料制备盐酸帕罗西汀缓释片,并对其质量进行评价。方法采用亲水凝胶骨架材料HPMC K100LV和K4M联用,通过干法制粒工艺制备盐酸帕罗西汀骨架片芯,然后通过肠溶薄膜包衣液对盐酸帕罗西汀骨架片芯进行包衣,获得盐酸帕罗西汀缓释片;以溶出曲线相似性f_2值作为评价指标,通过正交设计进行处方优化,用高效液相色谱法进行含量和杂质检测,通过加速和长期试验考察片剂稳定性。结果以该方法制备的盐酸帕罗西汀缓释片质量稳定,具有与原研制剂一致的溶出特征。结论该方法制备盐酸帕罗西汀缓释片具有可行性。 OBJECTIVE To prepare Paroxetine Hydrochloride Extended-release tablets by hydrophilic gel-forming matrix materials and assess the quality. METHODS Combined with two types of hydrophilic gel-forming matrix material of HPMC K100 LV and HPMC K4 M to prepare Paroxetine Hydrochloride Extended-release tablets. Paroxetine Hydrochloride Extended-release tablets were manufactured by the dry granulation process and then coated with enteric coating suspension. The formulations were optimized by orthogonal experiment design utilizing dissolution similarity f2 as an evaluation index. The drug content and impurity were analyzed by HPLC. The stability study was conducted under accelerated and long term conditions.RESULTS The optimized formulation of Paroxetine Hydrochloride Extended-release tablets showed acceptable quality and stability and similar dissolution profiles with the brand product. CONCLUSION This method to prepare Paroxetine Hydrochloride Extended-release tablets is feasible.
作者 刘洁凝 施祥杰 刘晓鸣 金婧 郭晓迪 LIU Jiening;SHI Xiangjie;LIU Xiaoming;JIN Jing;GUO Xiaodi(Zhejiang Huahai Pharmaceutical Co.,Ltd.,Linhai 317024,China)
出处 《中国现代应用药学》 CAS CSCD 北大核心 2019年第6期702-705,共4页 Chinese Journal of Modern Applied Pharmacy
关键词 亲水凝胶骨架材料 干法制粒 溶出曲线相似性 盐酸帕罗西汀缓释片 稳定性 hydrophilic gel-forming matrix materials dry granulation dissolution of the similarity Paroxetine Hydrochloride Extended-release tablets stability
  • 相关文献

参考文献1

二级参考文献21

  • 1Norman TR.Prospects for the treatment of depression[J].Aust N Z J Psychiatry,2006,40(5):394. 被引量:1
  • 2Goldstein DJ,Lu Y,Detke MJ,et al.Duloxetine in the treatment of depression:a double-blind placebo-controlled comparision with paroxetine[J].J Clin Psychopharmacol,2004,24(4):389. 被引量:1
  • 3Fava M,Mallinckrodt CH,Detke MJ,et al.The effect of duloxetine on painful physical symptoms in depressed patient:do improvements in these symptoms result in higher remission rates[J]? J Clin Psychiatry,2004,65(4):521. 被引量:1
  • 4Raskin J,Goldstien DJ,Mallinckrodt CH,et al.Duloxetine in the long-term treatment of major depressive disorder[J].J Clin Psychiatry,2003,64(10):1 237. 被引量:1
  • 5Bailey RK,Mallinckrodt CH,Wohlreich MM,et al.Duloxetine in the treatment of major depressive disorder:comparisons of safety and efficacy[J].J Natl Med Assoc,2006,98(3):437. 被引量:1
  • 6Perahia DG,Kajdasz DK,Walker DJ,et al.Duloxetine 60 mg once daily in the treatment of milder maior depressive disorder[J].Int J Clin Pract,2006,60(5):613. 被引量:1
  • 7Ozdemi V,Naranjo CA,Herrnannn N,et al.Paroxetine protentiates the central nervous systemside effects of perphenazine[J].Clin Pkarmacol Ther,1997,62:334. 被引量:1
  • 8Bonder RA,Lynch T,Lewis L,et al.Serotonin syndrome[J].Neurology,1995,45:219. 被引量:1
  • 9Ereshefsky L,Rieseman C,Francis Lam YW.Antidepressant drug interactions and the cytochrome P450 system[J].Clin Pharmackinet,1995,29(1):10. 被引量:1
  • 10Flesihaker JC,Hulst LK.A pharmacokinetics and pharmacodynamic evalution of the combined administration of alprazolame and fluvoxamine[J].Eur J Clin Pharmacol,1994,46:35. 被引量:1

共引文献13

同被引文献29

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部